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Abstract 17 
This study evaluated the effect of mass drug administration (MDA) with praziquantel administered 18 
to school-aged children (SAC) combined with „track and treat‟ of taeniosis cases in the general 19 
population on the copro-antigen (Ag) prevalence of taeniosis. The study was conducted in 14 20 
villages in Mbozi and Mbeya district, Tanzania. SAC made up 34% of the population and received 21 
MDA with praziquantel (40 mg/kg) in 2012 (both districts) and in 2013 (Mbozi only). Three cross-22 
© 2015. This manuscript version is made available under the Elsevier user license
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sectional population-based surveys were performed in 2012 (R0), 2013 (R1), and 2014 (R2). In 23 
each survey approximately 3,000 study subjects of all ages were tested for taeniosis using copro-24 
Ag-ELISA. In total 9,064 people were tested and copro-Ag-ELISA positive cases were offered 25 
treatment 6-8 months after sampling. The copro-Ag prevalence of taeniosis was significantly higher 26 
(Χ2-test, p=0.007) in Mbozi (3.0%) at R0 compared to Mbeya (1.5%). Twelve months after MDA 27 
in both districts (R1), the copro-Ag prevalence had dropped significantly in both Mbozi (2.0%, 28 
p=0.024) and in Mbeya (0.3%, p=0.004), but the significant difference between the districts 29 
persisted (Χ2-test, p<0.001). Ten months after the second round of MDA in Mbozi and 22 month 30 
after the first MDA (R2), the copro-Ag prevalence had dropped significantly again in Mbozi (0.8%, 31 
p<0.001), but had slightly increased in Mbeya (0.5%, p=0.051), with no difference between the two 32 
districts (Χ2-test, p=0.51). The taeniosis cases tracked and treated between round R0 and R2 33 
represented 9% of the projected total number of taeniosis cases within the study area, based on the 34 
copro-Ag prevalence and village population data. Among SAC in Mbozi, infection significantly 35 
decreased at R1 (p=0.004, OR 0.12 CI: 0.02-0.41) and R2 (p=0.001, OR 0.24, CI: 0.09-0.53) when 36 
comparing to R0. In Mbeya infection significant decreased at R1 (p=0.013, OR 0.14, CI: 0.02-37 
0.55), but no difference was found for R2 (p=0. 089), when comparing to R0 among SAC. This 38 
study showed that school-based MDA with praziquantel in combination with „track and treat‟ of 39 
taeniosis cases significantly reduced the copro-Ag prevalence of taeniosis, and that annual MDA 40 
was significantly better than single MDA. The persistence of taeniosis cases illustrates that a One 41 
Health approach must be emphasized for effective control.  42 
 43 
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1. Introduction 48 
Taenia solium taeniosis/cysticercosis is a growing and persistent problem in most sub-Saharan 49 
countries where pigs have been domesticated (Braae et al., 2015). Since humans are the sole 50 
definitive host of this zoonotic tapeworm, treatment of individuals with taeniosis is essential in the 51 
control of T. solium infection. Efficacious control tools for T. solium are available, but an algorithm 52 
for optimal tool combination for effective control is now needed. No studies assessing the effect of 53 
mass drug administration (MDA) with praziquantel on T. solium have been performed on the 54 
African continent to date. However, MDA campaigns have previously been used to treat humans in 55 
Latin America in efforts to control T. solium. Most studies have used porcine cysticercosis 56 
prevalence as an indicator of effect (Cruz et al., 1989; Garcia et al., 2006; Keilbach et al., 1989), 57 
and others have used prevalence of taeniosis as the measure of treatment effect. Diaz-Camacho et 58 
al. (1991) reported from Mexico that a reduction from 1% to 0% in taeniosis prevalence based on 59 
stool microscopy was seen one year after MDA with praziquantel (10 mg/kg). However, this was 60 
based only on four positive individuals at baseline, a detection methodology with low sensitivity, 61 
and no control group or statistical analysis. Another study from Mexico using copro-antigen (Ag)-62 
ELISA and stool microscopy showed a borderline significant (p=0.06) drop from 1.1% to 0.5% six 63 
months after a single round of community wide MDA with praziquantel (5 mg/kg) (Sarti et al., 64 
2000). In this study the prevalence remained at 0.5% 42 months post intervention. However, no 65 
comparison with a control group was made. Allan et al. (1997) reported from Guatemala that the 66 
4 
 
prevalence of taeniosis 10 months after MDA with niclosamide (coverage 75%) was, significantly 67 
(p<0.001) reduced from 3.5% to 1%, based on copro-Ag-ELISA and stool microscopy. However, 68 
no control group was included in this study. So far no studies have reported the effect of repeated 69 
rounds of MDA.  70 
 71 
Although theoretically controllable (Kyvsgaard et al., 2007) and declared eradicable by the 72 
International Task Force for Disease Eradication in 1993, T. solium taeniosis/cysticercosis remains 73 
a neglected zoonosis. This is not only due to a lack of available resources but also a lack of 74 
information about its burden, transmission, and validation of simple intervention packages (WHO, 75 
2010). The World Health Organisation (WHO) included T. solium cysticercosis as one of major 76 
Neglected Tropical Diseases in 2010 and recommended MDA as the primary intervention strategy 77 
against taeniosis (WHO, 2010), but to date no large scale taeniosis control programme has been 78 
implemented in sub-Saharan Africa.  79 
 80 
The drug praziquantel, which is effective against taeniosis at a dose as low as 5 mg/kg (Pawlowski, 81 
1991), is also used in MDA campaigns against schistosomiasis at a dose of 40 mg/kg. Praziquantel 82 
is being used extensively in a number of sub-Saharan African countries where schistosomiasis is 83 
prevalent. In countries where schistosomiasis and taeniosis are co-endemic there is the possibility to 84 
assess the impact on taeniosis of schistosomiasis control programmes using praziquantel. In 85 
Tanzania, school-based MDA with praziquantel is carried out as part of the National 86 
Schistosomiasis Control Programme (NSCP) in schistosomiasis endemic districts. This study aimed 87 
to assess the effect of repeated rounds of school-based MDA with praziquantel (40 mg/kg) in 88 
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combination with treatment of all taeniosis cases, in two areas co-endemic for T. solium 89 
taeniosis/cysticercosis and schistosomiasis. 90 
 91 
2. Methods 92 
2.1 Study area 93 
The study was carried out in Mbeya and Mbozi districts, Tanzania. The human population in 2012  94 
was estimated to be 305,319 in Mbeya district and 446,339 in Mbozi district (URT, 2013a). School-95 
aged children (SAC) and adults were defined as 4-15 years of age and 16 or above, respectively. In 96 
Mbozi and Mbeya districts SAC made up 35% and 33% of the total population, respectively (URT, 97 
2013b). Both districts are rural areas with high numbers of pigs kept primarily on a smallholder 98 
level, with 31,190 pigs in Mbeya district and 117,483 pigs in Mbozi district in 2007/2008 (URT, 99 
2012). Taenia solium taeniosis/cysticercosis is highly prevalent within the area (Braae et al., 2014; 100 
Komba et al., 2013; Mwanjali et al., 2013). No reports of bovine cysticercosis exist from the region 101 
and therefore the prevalence of T. saginata was expected to be negligible.  102 
 103 
2.2 Study design and sample size 104 
The NSCP carried out MDA with praziquantel to SAC in both districts between July and September 105 
2012 and in Mbozi district only in September 2013. Children not enrolled in school were 106 
encouraged to go and get treatment at the schools during the MDA. Following the MDA three 107 
community-based cross-sectional surveys were conducted  in 14 villages, eight in Mbeya district 108 
(total population 20,104) and six in Mbozi district (total population 18,025) (URT, 2013c). These 109 
14 villages were purposively selected based on knowledge of porcine cysticercosis presence 110 
(Komba et al., 2013), and made up four communities in each district. The first survey (R0) was 111 
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carried out in February to March 2012, second survey (R1) in July to August 2013, and the last 112 
survey (R2) in July to August 2014 (Figure 1). A sample size of approximately 1500 individuals 113 
from each district was targeted with all inhabitants willing to participate from each community 114 
included, with approximately 375 people from each community. Meetings informing about the 115 
study was carried out in each community prior to each survey. Hereafter, the villages were visited 116 
and all individuals invited to participate in the study. Different collection points were set up within 117 
each village where participants were provided with a plastic container and requested to submit a 118 
stool sample. In each district an active “track and treat” strategy was implemented to subsequently 119 
treat taeniosis cases with a single dose of 2g niclosamide for adults and 50 mg/kg for children in 120 
October 2012 after the first survey and praziquantel (10mg/kg) in March 2014 after the second 121 
survey. Since the “track and treat” followed the MDA children found positive for taeniosis could 122 
have been treated twice. 123 
 124 
2.3 Data collection and copro-Ag-ELISA 125 
All study subjects were interviewed and asked to complete a short questionnaire in order to collect 126 
information on demographics, latrine availability, recent (12 months) anthelminthic treatments as 127 
part of an MDA, and presence of pigs in the household. Each participant provided one stool sample 128 
of which one gram of faeces was stored in 10% formalin at room temperature for analysis. Stool 129 
samples were analysed for T. solium/saginata antigens at the University of Lusaka in Zambia using 130 
a copro-Ag-ELISA assay (Allan et al., 1990) with slight modifications (Mwape et al., 2012). The 131 
copro-Ag-ELISA assay has been reported to have an approximate sensitivity and specificity of 85% 132 
and 92%, respectively (Praet et al., 2013). 133 
  134 
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2.4 Ethical considerations 135 
Ethical approval was obtained from the National Institute for Medical Research (NIMR) reference 136 
number NIMR/HQ/R.8a/Vol. IX/1216. The study was also approved by the Imperial College 137 
Research Ethics Committee (ICREC), reference no. ICREC_11_3_6. Permission to conduct the 138 
study was sought through regional, district, and village authorities. Prior to each survey all study 139 
villages within the study area were visited and the community informed about the survey. Members 140 
of the community were given the opportunity to ask questions and seek more information about the 141 
study. Written informed consent was obtained from all participants after they were informed about 142 
the aim, risks, and benefits of the study. Individuals were informed about possible mild adverse 143 
effects of treatment such as stomach pain and nausea. If the person was under 18, consent was 144 
sought from a parent or guardian following assent from the participant. After each survey, and upon 145 
receiving the laboratory results, villages in the study area were visited, and village leaders, school 146 
headmasters and head teachers were informed about the results of the survey and copro-Ag-ELISA 147 
positive individuals were offered anthelminthic treatment within 6-8 months of sample collection. 148 
All people treated were provided with contact numbers of the district health officer and the medical 149 
doctor assigned to the treatment, and told to report any adverse events. 150 
 151 
2.5 Statistical methods 152 
Data were entered into EPI info 7 (http://wwwn.cdc.gov/epiinfo/7/) and transferred to an Excel 153 
spread sheet (Microsoft Office Excel 2010®) from where it was imported into the statistical 154 
programme R (http://www.r-project.org). Logistical regression and univariate analyses based on 155 
district, were used for the statistical analyses with p-values considered significant if smaller than 156 
0.05. Odds ratios (OR) and 95% confidence intervals (CI) are provide for significant factors. 157 
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 158 
3. Results 159 
3.1 Study population  160 
In total 9,064 stool samples were collected, 3,029 at R0, 3,021 at R1, and 3,014 at R2 (Table 1). 161 
The overall copro-Ag prevalence of taeniosis in the population of both districts was 2.2% at R0, 162 
1.2% at R1, and 0.7% at R2 (Figure 2). Among the study subjects found positive for taeniosis, 62 163 
out of 67 and 29 out of 35 were tracked and treated when revisited after R0 and R1, respectively. Of 164 
the treated study subjects overall, 27 were from Mbeya district and 64 from Mbozi district. Based 165 
on the theoretical number of tapeworm carriers within the study area as the denominator (number of 166 
people per village multiplied with taeniosis copro-Ag prevalence) this corresponds to both 9% of all 167 
tapeworm carriers treated within each district and overall for both districts.   168 
 169 
Logistic regression including data from the whole study period revealed a drop in infection at R1 170 
(P<0.001, OR 0.49, CI: 0.32-0.74) twelve months after the MDA in both districts and at R2 ten 171 
months after the second round of MDA in Mbozi and 22 months after the first MDA (P<0.001, OR 172 
0.38, CI: 0.22-0.62) when compared to R0 and controlling for age groups (SAC/Adults) and sex. 173 
Logistic regression analyses revealed that the risk of being infected with T. solium was significantly 174 
greater for males than females (p=0.004, OR 1.73, CI: 1.20-2.52). There was also an increased risk 175 
for adults compared to SAC throughout the study period (p<0.001, OR 2.39, CI: 1.64-3.50). Living 176 
in Mbozi district was associated with a higher risk of taeniosis infection compared to living in 177 
Mbeya district (p<0.001, OR 2.35, CI: 1.59-3.53). 178 
  179 
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From each of the three questionnaire surveys it was found that 54, 46, and 38 people, respectively, 180 
did not have access to a latrine and 606, 460, and 502, respectively, said they were keeping pigs. 181 
Neither lack of latrines or presence of pigs at the household could be associated with taeniosis in 182 
this study. During the study period there was a large drop in the number of people stating to have 183 
seen “worms” in their stool during the last 12 months, from 612 (20%) at R0 and 590 (20%) at R1, 184 
to 179 (6%) at R2. However, this could not be associated with infection. 185 
 186 
3.2 District comparison 187 
Between the two districts univariate analysis show that at baseline (R0), the copro-Ag prevalence of 188 
taeniosis was significantly higher (Χ2-test, p=0.007) in Mbozi district (3.0%) compared to Mbeya 189 
district (1.5%). The copro-Ag prevalence had significantly dropped in both Mbozi district (2.0%, 190 
p=0.024) and in Mbeya district (0.3%, p=0.004) at R1, but the significant difference between the 191 
districts persisted (Χ2-test, p<0.001). Ten months after the second round of MDA in Mbozi district 192 
and 22 month after the first MDA (R2), the copro-Ag prevalence had significantly dropped further 193 
in Mbozi district (0.8%, p<0.001), but had slightly increased in Mbeya district (0.5%, p=0.051). At 194 
this time point there was no difference in taeniosis copro-Ag prevalence between the two districts 195 
(Χ2-test, p=0.51).  196 
 197 
Analysis of the data from Mbozi district using logistic regression showed a decrease in infection at 198 
both R1 (p=0.022, OR 0.57, CI: 0.35-0.92) and R2 (p=0.001, OR 0.33, CI: 0.17-0.62) when 199 
compared to R0 and controlling for age groups and sex. The logistic regression further revealed 200 
males to be more associated with infection (p=0.013, OR 1.75, CI: 1.13-2.74) as well as adults 201 
(p<0.001, OR 2.84, CI: 1.80-4.55). The same analysis for Mbeya district showed a significant 202 
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decrease in infection from R0 to R1 (p=0.004, OR 0.24, CI: 0.08-0.58) and a significant decrease in 203 
infection from R0 to R2 (p=0.047, OR 0.42, CI: 0.17-0.96). There was no association found 204 
between infection and age groups (p=0.33) or sex (p=0.13).    205 
 206 
3.3 School-aged children population comparison  207 
Logistic regression analysis based on stool samples from SAC alone showed that in Mbozi district 208 
infection significantly decreased at R1 (p=0.004, OR 0.12 CI: 0.02-0.41) and R2 (p=0.001, OR 209 
0.24, CI: 0.09-0.53) when comparing to R0. There was no association between sex and infection. 210 
The same analysis for Mbeya district among SAC showed that infection significant decreased at R1 211 
(p=0.013, OR 0.14, CI: 0.02-0.55), but no difference was found for R2 (p=0. 089), when comparing 212 
to R0 (Figure 2). There was no difference between sexes. Overall, 95% (35/37) of positive SAC 213 
were tracked and treated between R0 and R2. In Mbeya district all positive SAC were tracked and 214 
treated after R0 (11/11) and R1 (2/2). In Mbozi district 20 SAC, equivalent to 91% (20/22) of 215 
positives, were tracked and treated after R0, and all (2/2) SAC were tracked and treated after R1. 216 
Based on the SAC population of the villages and the copro-Ag prevalence found at R0 and R1 this 217 
corresponded to 13% of all taeniosis cases within the villages. 218 
  219 
3.4 Adult population comparison 220 
Focusing on the adult population, logistic regression showed that in Mbozi district there was no 221 
difference in infection between R0 and R1 (p=0.65) or between R0 and R2 (p=0.11). Males where 222 
more likely to be infected with a tapeworm (p=0.019, OR 1.99, CI: 1.13-3.60) compared to females. 223 
In Mbeya district no difference could be seen between infection at survey R1 (p=0.15) or R2 224 
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(p=0.99) compared to R0 (Figure 2). Nor could sex be associated with disease. Overall, 86% 225 
(54/63) of positive adults were tracked and treated between R0 and R2. Positive adults were all 226 
tracked and treated in Mbeya district after R0 (11/11) and R1 (3/3). In Mbozi district 20, equivalent 227 
to 87% (20/23) of the positive adults were tracked and treated after R0, and 22, equivalent to 79% 228 
(22/28) of the positive adults were tracked and treated after R1. Based on the adult population of the 229 
villages and the copro-Ag prevalence found at R0 and R1 this corresponded to 4% of all taeniosis 230 
cases within the villages. 231 
 232 
4. Discussion 233 
This is, to our knowledge, the first study assessing the effect of MDA of praziquantel on the copro-234 
Ag prevalence of taeniosis in Africa, and the first to assess the effect of repeated MDA. The study 235 
showed that school-based MDA with praziquantel in combination with „track and treat‟ of taeniosis 236 
cases significantly reduced the copro-Ag prevalence of taeniosis among SAC. It also demonstrated 237 
that annual MDA was significantly more effective in reducing taeniosis copro-Ag prevalence than a 238 
single MDA. Although no spill-over effect could be seen into the adult population it is likely that, 239 
due to the zoonotic nature of the parasite, this effect would take time to become evident. No 240 
measureable effect of „track and treat‟ was seen in the adult population, and proportionately „track 241 
and treat‟ was less successful in locating cases among the adult population compared to the SAC 242 
population.  243 
 244 
The effect of MDA with praziquantel on taeniosis prevalence has been difficult to establish from 245 
previous studies due to lack of comparison groups (Carabin and Traoré, 2014). Overall for the 246 
entire study population it was not possible to detect a significant difference in copro-Ag prevalence 247 
12 
 
of taeniosis between to two MDA schemes. However, this study showed an effect of school-based 248 
MDA in the target population, and when comparing two different treatment schemes, showed 249 
annual MDA to be better compared with a single MDA. The copro-Ag prevalence of taeniosis 250 
among SAC under the annual MDA remained at a significant lower level compared to baseline (R0) 251 
during both follow-up surveys (R1 and R2). The lack of difference found from baseline (R0) to 22 252 
months after the MDA (R2) among the SAC that had only received MDA once supported annual 253 
MDA being better than a single MDA, but was in contrast to the long-term effect of MDA reported 254 
from Latin America by Sarti et al. (2000). It is unknown how fast the parasite returns to pre-255 
treatment levels after intervention has stopped, but according to the model published by Kyvsgaard 256 
et al. (2007) it occurs rapidly. In Peru one study tried to estimate the effect of MDA of both humans 257 
(praziquantel) and pigs (oxfendazole) (Garcia et al., 2006). The effect was measured based on 258 
prevalence and incidence of porcine cysticercosis and the authors concluded that there was a small 259 
effect of the MDA, and infection pressure stabilised at decreased rates post treatment. The problem 260 
with measuring the effect of MDA on humans based on porcine cysticercosis prevalence is that, 261 
treatment might reduce the number of tapeworm carriers, but the environment may stay 262 
contaminated for an extended period of time (Ilsoe et al., 1990), diluting the immediate effect of the 263 
MDA depending on the transmission rate from the environment to pigs. Incidence of porcine 264 
cysticercosis may be a more feasible approach to quantify the environmental contamination 265 
(Gonzalez et al., 1994; Ngowi et al., 2008). The drop in reports of “worms” seen in the stool of the 266 
study subjects in our study was consistent with the downward trend in taeniosis copro-Ag 267 
prevalence, but might also be due to reduction in Ascaris infection. 268 
 269 
Although school-based MDA only targets a proportion of the total population, it presents fewer 270 
logistical challenges and might be more feasible and in some cases cost-effective compared to 271 
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community-based MDA. In Mbozi and Mbeya districts SAC constitutes a relatively large 272 
proportion (34%) of the general population and might therefore be a cost-effective alternative to 273 
community-based MDA. The lack of a measurable spill-over from the school-based MDA, into the 274 
adult population could be due to the limited time scale of this study. An important limitation of the 275 
study was the low sample size among the adult population towards the end of the study. This 276 
resulted in any potential spill-over effect of the school-based MDA into the adult population, being 277 
difficult to detect. It was not determined whether a specific SAC had been treated with praziquantel 278 
as part of the NSCP, or to what extent the same SAC were repeatedly sampled during the surveys. 279 
 280 
„Track and treat‟ was successfully carried out, and only few individuals did not receive treatment, 281 
the majority of whom were adults. Proportionately, fewer theoretical adult cases (4%) within the 282 
study area were treated compared to SAC (13%). No significant decrease in copro-Ag prevalence 283 
was seen throughout the study among the adults. This could be due to the small sample size of the 284 
last survey (R2). It would be interesting to see if tripling the sample size of adults, thereby 285 
increasing the theoretically number of cases treated using „track and treat‟ from 4% to 12%, 286 
reaching the approximate proportion of that in SAC (13%), would yield similar results as was seen 287 
among SAC in this study. This may provide a more accurate indication of the potential benefit of 288 
MDA versus „track and treat‟.  289 
 290 
Males were generally found to be more at risk of T. solium infection than females in this study. 291 
However, this is in contrast to a study from Latin America where females were more likely to have 292 
taeniosis (Allan et al., 1996). This difference might be explained by cultural differences that exist 293 
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between the regions, resulting in differences in risk behaviour among men and women, which 294 
influence the transmission of the parasite.  295 
 296 
In Guatemala, Allan et al. (1996) found a peak in taeniosis prevalence among the 30-39 year olds. 297 
Similar in this study, the increased risk among adults suggests either increased risk behaviour with 298 
age, increased household exposure with repeated infection, or that T. solium is long lived meaning 299 
prolonged exposure is linked with greater risk of infection. In contrast, the low prevalence of 300 
taeniosis suggests that either, the tapeworm has a much shorter life span than anecdotally suggested 301 
in the literature, or establishment of infection is a rare event. This could be for two reasons; 1) 302 
infected pork with viable cysts is infrequently ingested, or 2) ingested cysts rarely result in 303 
establishment of a tapeworm. If the incidence rate of infections is extremely low, then the treatment 304 
of positives carried out in both districts after each survey could have great impact on the results and 305 
cloud the potential effect of an MDA. 306 
 307 
Pigs or latrine presence and frequency of usage were not associated with infection. Although, these 308 
are logical risk factors, the study was restricted since the information was based on questionnaires 309 
and not observations which would have given the data more validity. Also, pigs are not slaughtered 310 
and consumed within the households, but are traded and consumed at local markets, resulting in 311 
general risk to the public consuming pork and not necessarily to the residents of households rearing 312 
infected pigs. There was a difference in the ratio of pigs and humans between the two districts, but 313 
on a village level the differences are expected to be minuscule, because some villages keep pigs 314 
while others do not. Therefore the numbers vary on the district level, but less so on a village level. 315 
 316 
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Results from this study demonstrate, for the first time, that repeated administration of praziquantel 317 
using a school based approach and part of an established schistosomiasis control programme, can 318 
have a significant impact on T .solium prevalence. This is an important finding as integration of 319 
treatment of neglected diseases will ensure that the limited resources allocated will be used in the 320 
most cost-effective manner. Increased availability of donated praziquantel, currently for the 321 
treatment of schistosomiasis, could also make a contribution to the control of T. solium in the 322 
future, but using praziquantel at the dose recommended for schistosomiasis treatment might 323 
increase the risk of seizures in people who are suffering from human cysticercosis, and still needs to 324 
be evaluated in co-endemic areas (Braae et al., 2015). It is also clear that due to the zoonotic 325 
potential of T. solium, control and eventually elimination will require a One Health approach 326 
consisting of a combination of control tools from both the human and veterinary public health 327 
sectors. An algorithm with those control tools is therefore still needed. Further monitoring of 328 
prevalence and the establishment of incidence rates of taeniosis in co-endemic areas along with the 329 
combination of other control tools should pave the road forward to elimination. 330 
 331 
5. Acknowledgements 332 
The study was conducted under the Bill and Melinda Gates foundation funded ICTC-project 333 
(Integrated Control of Taeniosis/Cysticercosis in sub-Saharan Africa). To all inhabitants of Mbeya 334 
and Mbozi districts who agreed to participate and thereby made the study possible. To the field 335 
team for all the hours spend in the field. To Drs Chummy Sikasunge and Kabemba Evans Mwape 336 
from the University of Zambia for their technical assistance with the copro-Ag-ELISA assays. 337 
 338 
6. References 339 
16 
 
Allan, J., Velasquez-Tohom, M., Garcia-Noval, J., Torres-Alvarez, R., Yurrita, P., Fletes, C., De 340 
Mata, F., Soto, d.A.H., Craig, P., 1996. Epidemiology of intestinal taeniasis in four, rural, 341 
Guatemalan communities. Ann. Trop. Med. Parasitol. 90, 157-165. 342 
Allan, J.C., Avila, G., Noval, J.G., Flisser, A., Craig, P.S., 1990. Immunodiagnosis of taeniasis by 343 
coproantigen detection. Parasitology 101, 473-477. 344 
Allan, J.C., VelasquezTohom, M., Fletes, C., TorresAlvarez, R., LopezVirula, G., Yurrita, P., 345 
deAlfaro, H.S., Rivera, A., GarciaNoval, J., 1997. Mass chemotherapy for intestinal Taenia solium 346 
infection: effect on prevalence in humans and pigs. Trans. R. Soc. Trop. Med. Hyg. 91, 595-598. 347 
Braae, U., Saarnak, C., Mukaratirwa, S., Devleesschauwer, B., Magnussen, P., Johansen, M., 2015. 348 
Taenia solium taeniosis/cysticercosis and the co-distribution with schistosomiasis in Africa. Parasit. 349 
Vectors. 8, 323. 350 
Braae, U.C., Magnussen, P., Lekule, F., Harrison, W., Johansen, M.V., 2014. Temporal fluctuations 351 
in the sero-prevalence of Taenia solium cysticercosis in pigs in Mbeya Region, Tanzania. Parasit. 352 
Vectors. 7, 574. 353 
Carabin, H., Traoré, A.A., 2014. Taenia solium Taeniasis and Cysticercosis Control and 354 
Elimination Through Community-Based Interventions. Curr. Trop. Med. Rep., 1-13. 355 
Cruz, M., Davis, A., Dixon, H., Pawlowski, Z.S., Proano, J., 1989. Operrational studies on the 356 
control of Taenia solium taeniasis/cysticercosis in Ecuador. Bulletin of the World Health 357 
Organization 67, 401-407. 358 
Diaz-Camacho, S.P., Ruiz, A.C., Peraza, V.S., Ramos, M.L.Z., Medina, M.F., Lozano, R., Willms, 359 
K., 1991. Epidemiologic study and control of Taenia solium infections with praziquantel in a rural 360 
village of Mexico. Am J Trop Med Hyg 45, 522-531. 361 
17 
 
Garcia, H.H., Gonzalez, A.E., Gilman, R.H., Moulton, L.H., Verastegui, M., Rodriguez, S., 362 
Gavidia, C., Tsang, V.C.W., Cysticercosis Working, G., 2006. Combined human and porcine mass 363 
chemotherapy for the control of T. solium. Am J Trop Med Hyg 74, 850-855. 364 
Gonzalez, A.E., Gilman, R., Garcia, H.H., McDonald, J., Kacena, K., Tsang, V., Pilcher, J.B., 365 
Suarez, F., Gavidia, C., Miranda, E., 1994. Use of sentinel pigs to monitor environmental Taenia 366 
solium contamination. The Cysticercosis Working Group in Peru (CWG). The American journal of 367 
tropical medicine and hygiene 51, 847-850. 368 
Ilsoe, B., Kyvsgaard, N.C., Nansen, P., Henriksen, S.A., 1990. A study on the survival of Taenia 369 
saginata eggs on soil in Denmark. Acta Vet. Scand. 31, 153-158. 370 
Keilbach, N.M., De Aluja, A.S., Sarti-Gutierrez, E., 1989. A program to control taeniasis-371 
cysticercosis (Taenia solium): Experiences in a Mexican village. Acta Leiden 57, 181-190. 372 
Komba, E.V., Kimbi, E.C., Ngowi, H.A., Kimera, S.I., Mlangwa, J.E., Lekule, F.P., Sikasunge, 373 
C.S., Willingham III, A.L., Johansen, M.V., Thamsborg, S.M., 2013. Prevalence of porcine 374 
cysticercosis and associated risk factors in smallholder pig production systems in Mbeya region, 375 
southern highlands of Tanzania. Vet. Parasitol. 198, 284-291. 376 
Kyvsgaard, N.C., Johansen, M.V., Carabin, H., 2007. Simulating transmission and control of 377 
Taenia solium infections using a Reed-Frost stochastic model. Int. J. Parasitol. 37, 547-558. 378 
Mwanjali, G., Kihamia, C., Kakoko, D.V.C., Lekule, F., Ngowi, H., Johansen, M.V., Thamsborg, 379 
S.M., Willingham, A.L., 3rd, 2013. Prevalence and risk factors associated with human Taenia 380 
solium infections in Mbozi district, Mbeya Region, Tanzania. Plos Negl. Trop. Dis. 7, e2102. 381 
Mwape, K.E., Phiri, I.K., Praet, N., Muma, J.B., Zulu, G., Van den Bossche, P., de Deken, R., 382 
Speybroeck, N., Dorny, P., Gabriel, S., 2012. Taenia solium Infections in a Rural Area of Eastern 383 
Zambia - A Community Based Study. Plos Negl. Trop. Dis. 6. 384 
18 
 
Ngowi, H.A., Carabin, H., Kassuku, A.A., Mlozi, M.R.S., Mlangwa, J.E.D., Willingham, A.L., 385 
2008. A health-education intervention trial to reduce porcine cysticercosis in Mbulu District, 386 
Tanzania. Prev. Vet. Med. 85, 52-67. 387 
Pawlowski, Z.S., 1991. Efficacy of low doses of praziquantel in taeniasis. Acta Trop. 48, 83-88. 388 
Praet, N., Verweij, J.J., Mwape, K.E., Phiri, I.K., Muma, J.B., Zulu, G., van Lieshout, L., 389 
Rodriguez-Hidalgo, R., Benitez-Ortiz, W., Dorny, P., Gabriel, S., 2013. Bayesian modelling to 390 
estimate the test characteristics of coprology, coproantigen ELISA and a novel real-time PCR for 391 
the diagnosis of taeniasis. Trop Med Int Health 18, 608-614. 392 
Sarti, E., Schantz, P.M., Avila, G., Ambrosio, J., Medina-Santillan, R., Flisser, A., 2000. Mass 393 
treatment against human taeniasis for the control of cysticercosis: a population-based intervention 394 
study. Trans. R. Soc. Trop. Med. Hyg. 94, 85-89. 395 
URT, 2012. National Sample Census of Agriculture 2007/2008. Volume VI: Regional Report: 396 
Mbeya Region, Tanzania: National Bureau of Statistics, pp. 1-326. 397 
URT, 2013a. Population and Housing Census 2012 Report, Tanzania: National Bureau of Statistics, 398 
pp. 1-244. 399 
URT, 2013b. Population and Housing Census 2012 Report - Age & Sex Distribution, Tanzania: 400 
National Bureau of Statistics, pp. 1-244. 401 
URT, 2013c. Population and Housing Census 2012 Report - Village Statistics, Tanzania: National 402 
Bureau of Statistics, pp. 1-244. 403 
WHO, 2010. Working to overcome the global impact of neglected tropical diseases - First WHO 404 
report on neglected tropical diseases, Geneva: World Health Organization. 405 
 406 
19 
 
Figure legends: 407 
 408 
Figure 1: Schematic illustration of the study design with school-based mass drug administration 409 
(MDA) with praziquantel (40 mg/kg) to school-aged children (SAC) aged 4-15, „track and treat‟ of 410 
taeniosis positive people within the whole population, and three cross-sectional data collection 411 
points on taeniosis prevalence (R0 Feb/Mar 2012, R1 Jul/Aug 2013, and R2 July/Aug 2014). 412 
 413 
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Figure 2: Taeniosis prevalence in school-aged children (SAC) aged 4-15, adults (>15), and both 415 
groups in the two districts Mbozi and Mbeya during the three cross-sectional surveys R0, R1, and 416 
R2. Asterisk (*) illustrates significant difference with baseline (R0) based on logistic regression 417 
with *p=0.01-0.05 and **p=0.001-0.009. The error bars depict the 95% binomial confidence 418 
intervals based on sample size and number of positives.  419 
 420 
Table legends: 421 
Table 1: Study population characteristics, and prevalence of taeniosis in the two districts Mbozi 422 
and Mbeya during the three surveys. 423 
Survey  R0  R1  R2 
District  Mbozi Mbeya  Mbozi Mbeya  Mbozi Mbeya 
Stool samples  1519
a 
1510
b 
 1500
c 
1521
d 
 1514 1500 
Males %  50 50  52 48  46 45 
Females %  51 49  48 52  54 55 
Children (4-15)  951 880  712 1098  1255 1400 
Adults (16-87)  561 621  786 422  259 100 
Taeniosis (%)  45 (3.0) 22 (1.5)  30 (2.0) 5 (0.3)  12 (0.8) 8 (0.5) 
Taeniosis in children (%)  22 (2.3) 11 (1.3)  2 (0.3) 2 (0.2)  7 (0.6) 8 (0.6) 
Taeniosis in adults (%)  23 (4.1) 11 (1.8)  28 (3.6) 3 (0.7)  5 (1.9) 0 (0.0) 
aSex was not recorded for 7 individuals 424 
bSex was not recorded for 9 individuals 425 
cSex was not recorded for 2 individuals 426 
dSex was not recorded for 1 individual 427 
 428 
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